Could melatonin help kids with PTSD sleep better?
NCT ID NCT07418554
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether a slow-release form of melatonin can improve sleep in 120 children and adolescents (ages 2-17.5) with PTSD who have significant sleep disturbances. Participants will receive either melatonin or a placebo for 13 weeks. The study aims to see if melatonin increases total sleep time and reduces PTSD symptoms, daytime problems, and caregiver stress.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
prolonged-release melatonin
What this could lead to
If it works, this could provide a safe, effective treatment for sleep problems in children with PTSD, improving their daytime functioning and mental health.
What could go wrong
This is an early-stage trial with only 120 participants. Melatonin may not work for PTSD-related sleep issues, and individual results may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER (PTSD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••